Related Experiment Video
Updated: May 17, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and
Prem Shankar Gupta1, Vijay Sharma, Kamla Pathak
1Department of Pharmaceutics, Rajiv Academy for Pharmacy, NH-2, PO Chattikara, Mathura 281001, Uttar Pradesh, India.
Objectives:
The present study investigates the effect of particle engineering technique on powder properties and pharmacokinetics of piroxicam (PXM).
Methods:
PXM was subjected to melt sonocrystallization to obtain product designated as MSCPXM and characterized for various pharmacotechnical parameters, performance characteristics and pharmacokinetic evaluation.
Results:
Micromeritic and rheological properties were found to be superior to the original form (OFPXM). On melt sonocrystallization, solubility and intrinsic dissolution rate were enhanced by 76.45% and 33.33%, respectively. Solid state evaluation by DSC and XRPD ruled out possibilities of polymorph formation but confirmed decreased crystallinity index. SEM analysis revealed uniformly shaped smaller drug particles of MSCPXM as compared to PXM. The thermodynamic stability of MSCPXM was monitored by XRPD and the sample was stable even after 3 months of storage at 40 ± 2°C and 75 ± 5% RH. The MSCPXM was formulated as immediate release tablets (F1 - F4) and evaluated with reference tablets of OFPXM (F0). F2 was identified as best formulation with suitable tablet characteristics and in-vitro drug release profile. Pharmacokinetic evaluation of F2 in rats supported the in-vitro data with 2.08-fold increase in bioavailability achieved at 4.8 ± 1.7 h with MSCPXM as compared to OFPXM.
Conclusions:
Conclusively, melt sonocrystallization offered an efficient, solvent-free technique that can be exploited for particle designing of drugs with favorable pharmaceutical properties.
Related Concept Videos
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
